Active, Not Recruiting Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas NCT04924608 Conditions Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more Locations Research Site — Gainesville, Florida, United States Research Site — Rockville, Maryland, United States Research Site — St Louis, Missouri, United States Research Site — Commack, New York, United States View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details
